FDA Grant Establishes Complex Generics Center To Increase Access

Key Component Of The FDA’s Drug Competition Action Plan

 
• By Dean Rudge
  
FDAEntrance_1200x675
Complex products are a key component of the FDA’s Drug Competition Action Plan • Source: Shutterstock

More from Regulation

More from Policy & Regulation